Substrate source utilisation in long-term diagnosed type 2 diabetes patients at rest, and during exercise and subsequent recovery

Diabetologia

Volumn 50, Issue 1, 2007, Pages 103-112

  Boon, H ^a   Blaak, E E ^a   Saris, W H M ^a   Keizer, H A ^b,c   Wagenmakers, A J M ^d   Van Loon, L J C ^a,b  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c FREE UNIVERSITY OF BRUSSELS   (Belgium)

^d UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Exercise; IMTG; Stable isotopes; Substrate source metabolism; Type 2 diabetes

Indexed keywords

FATTY ACID; GLUCOSE; GLYCOGEN; PALMITIC ACID; TRACER; TRIACYLGLYCEROL;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC PATIENT; EXERCISE; EXERCISE RECOVERY; FATTY ACID BLOOD LEVEL; GLUCOSE BLOOD LEVEL; GLUCOSE OXIDATION; GLYCOGEN ANALYSIS; HUMAN; MALE; MUSCLE BIOPSY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OXIDATION; PRIORITY JOURNAL; REST; STATISTICAL SIGNIFICANCE;

BIOPSY; BLOOD GLUCOSE; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; ENERGY METABOLISM; EXERCISE; FATTY ACIDS, NONESTERIFIED; GLYCEROL; GLYCOGEN; HUMANS; INSULIN; LIPID METABOLISM; MALE; MIDDLE AGED; MUSCLE, SKELETAL; OBESITY; REST;

EID: 33845971547     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-006-0482-2     Document Type: Article

References (45)

1. Goodpaster BH, Kelley DE, Wing RR, Meier A, Thaete FL (1999) Effects of weight loss on regional fat distribution and insulin sensitivity in obesity. Diabetes 48:839-847
2. van Loon LJC, Koopman R, Manders R, van der Weegen W, van Kranenburg GP, Keizer HA (2004) Intramyocellular lipid content in type 2 diabetes patients compared to overweight sedentary men and highly trained endurance athletes. Am J Physiol Endocrinol Metab 287:E558-EE565
3. Thamer C, Machann J, Bachmann O et al (2003) Intramyocellular lipids: anthropometric determinants and relationships with maximal aerobic capacity and insulin sensitivity. J Clin Endocrinol Metab 88:1785-1791
4. Yu C, Chen Y, Cline GW et al (2002) Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle. J Biol Chem 277:50230-50236
5. Shulman GI (2000) Cellular mechanisms of insulin resistance. J Clin Invest 106:171-176
6. Roden M, Price TB, Perseghin G et al (1996) Mechanism of free fatty acid-induced insulin resistance. J Clin Invest 97:2859-2865
7. Russell AP, Gastaldi G, Bobbioni-Harsch E et al (2003) Lipid peroxidation in skeletal muscle of obese as compared to endurance-trained humans: a case of good vs. bad lipids? FEBS Lett 551:104-106
8. Adams II JM, Pratipanawatr T, Berria R et al (2004) Ceramide content is increased in skeletal muscle from obese insulin-resistant humans. Diabetes 53:25-31
9. Ellis BA, Poynten A, Lowy AJ et al (2000) Long-chain acyl-CoA esters as indicators of lipid metabolism and insulin sensitivity in rat and human muscle. Am J Physiol Endocrinol Metab 279:E554-E560
10. Itani SI, Ruderman NB, Schmieder F, Boden G (2002) Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IkappaB-alpha. Diabetes 51:2005-2011
11. Blaak EE, Wagenmakers AJM, Glatz JFC et al (2000) Plasma FFA utilization and fatty acid-binding protein content are diminished in type 2 diabetic muscle. Am J Physiol Endocrinol Metab 279:E146-E154
12. Felber JP, Ferrannini E, Golay A et al (1987) Role of lipid oxidation in pathogenesis of insulin resistance of obesity and type II diabetes. Diabetes 36:1341-1350
13. Golay A, Felber JP, Meyer HU, Curchod B, Maeder E, Jequier E (1984) Study on lipid metabolism in obesity diabetes. Metabolism 33:111-116
14. Kelley DE, Simoneau J-A (1994) Impaired free fatty acid utilization by skeletal muscle in non-insulin dependent diabetes mellitus. J Clin Invest 94:2349-2356
15. Kang J, Kelley DE, Robertson RJ et al (1999) Substrate utilization and glucose turnover during exercise of varying intensities in individuals with NIDDM. Med Sci Sports Exerc 31:82-89
16. Blaak EE, van Aggel-Leijssen DPC, Wagenmakers AJM, Saris WHM, van Baak MA (2000) Impaired oxidation of plasma-derived fatty acids in type 2 diabetic subjects during moderate-intensity exercise. Diabetes 49:2102-2107
17. Borghouts LB, Wagenmakers AJM, Goyens PLL, Keizer HA (2002) Substrate utilization in non-obese type II diabetic patients at rest and during exercise. Clin Sci 103:559-566
18. Colberg SR, Hagberg JM, McCole SD, Zmuda JM, Thompson PD, Kelley DE (1996) Utilization of glycogen but not plasma glucose is reduced in individuals with NIDDM during mild-intensity exercise. J Appl Physiol 81:2027-2033
19. Taskinen MR, Bogardus C, Kennedy A, Howard BV (1985) Multiple disturbances of free fatty acid metabolism in noninsulin-dependent diabetes. Effect of oral hypoglycemic therapy. J Clin Invest 76:637-644
20. Kelley DE, Mandarino LJ (1990) Hyperglycemia normalizes insulin-stimulated skeletal muscle glucose oxidation and storage in noninsulin-dependent diabetes mellitus. J Clin Invest 86:1999-2007
21. Mensink M, Blaak EE, van Baak MA, Wagenmakers AJM, Saris WHM (2001) Plasma free fatty acid uptake and oxidation are already diminished in subjects at high risk for developing type 2 diabetes. Diabetes 50:2548-2554
22. van Loon LJC (2004) Use of intramuscular triacylglycerol as a substrate source during exercise in humans. J Appl Physiol 97:1170-1187
23. Minuk HL, Vranic M, Marliss EB, Hanna AK, Albisser AM, Zinman B (1981) Glucoregulatory and metabolic response to exercise in obese noninsulin-dependent diabetes. Am J Physiol 240:E458-E464
24. Martin IK, Katz A, Wahren J (1995) Splanchnic and muscle metabolism during exercise in NIDDM patients. Am J Physiol 269:E583-E590
25. Alberti KG, Zimmet PZ (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15:539-553
26. Siri WE (1956) The gross composition of the body. Adv Biol Med Phys 4:239-280
27. 13C] acetate recovery factor in metabolic research. Eur J Appl Physiol 89:377-383
28. Bergstrom J (1975) Percutaneous needle biopsy of skeletal muscle in physiological and clinical research. Scand J Clin Lab Invest 35:609-616
29. Peronnet F, Massicotte D (1991) Table of nonprotein respiratory quotient: an update. Can J Sport Sci 16:23-29
30. Wolfe RR, Jahoor F (1990) Recovery of labeled CO2 during the infusion of C-1- vs C-2-labeled acetate: implications for tracer studies of substrate oxidation. Am J Clin Nutr 51:248-252
31. Sidossis LS, Coggan AR, Gastaldelli A, Wolfe RR (1995) A new correction factor for use in tracer estimations of plasma fatty acid oxidation. Am J Physiol 269:E649-E656
32. Schrauwen P, van Aggel-Leijssen DPC, van Marken Lichtenbelt WD, van Baak MA, Gijsen AP, Wagenmakers AJM (1998) Validation of the [1,2-13C] acetate recovery factor for correction of [U-13C] palmitate oxidation rates in humans. J Physiol 513:215-223
33. Jeukendrup AE, Raben A, Gijsen A et al (1999) Glucose kinetics during prolonged exercise in highly trained human subjects: effect of glucose ingestion. J Physiol 515:579-589
34. Trimmer JK, Casazza GA, Horning MA, Brooks GA (2001) Recovery of (13)CO2 during rest and exercise after [1-(13)C] acetate, [2-(13)C]acetate, and NaH(13)CO3 infusions. Am J Physiol Endocrinol Metab 281:E683-E692
35. Schaart G, Hesselink RP, Keizer HA, van Kranenburg G, Drost MR, Hesselink MK (2004) A modified PAS stain combined with immunofluorescence for quantitative analyses of glycogen in muscle sections. Histochem Cell Biol 122:161-169
36. Sacchetti M, Olsen DB, Saltin B, van Hall G (2005) Heterogeneity in limb fatty acid kinetics in type 2 diabetes. Diabetologia 48:938-945
37. Campbell PJ, Carlson MG, Nurjhan N (1994) Fat metabolism in human obesity. Am J Physiol 266:E600-E605
38. Eriksson JW, Smith U, Waagstein F, Wysocki M, Jansson PA (1999) Glucose turnover and adipose tissue lipolysis are insulin-resistant in healthy relatives of type 2 diabetes patients: is cellular insulin resistance a secondary phenomenon? Diabetes 48:1572-1578
39. Frayn KN (2005) Obesity and metabolic disease: is adipose tissue the culprit? Proc Nutr Soc 64:7-13
40. Groop LC, Bonadonna RC, DelPrato S et al (1989) Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus. Evidence for multiple sites of insulin resistance. J Clin Invest 84:205-213
41. Martin WH (1997) Effect of endurance training on fatty acid metabolism during whole body exercise. Med Sci Sports Exerc 29:635-639
42. Hayashi T, Wojtaszewski JF, Goodyear LJ (1997) Exercise regulation of glucose transport in skeletal muscle. Am J Physiol 273:E1039-E1051
43. Blaak EE (2003) Fatty acid metabolism in obesity and type 2 diabetes mellitus. Proc Nutr Soc 62:753-760
44. Schrauwen P, Hesselink MKC (2004) Oxidative capacity, lipotoxicity, and mitochondrial damage in type 2 diabetes. Diabetes 53:1412-1417
45. Blaak EE, Wagenmakers AJ (2002) The fate of [U-(13)C] palmitate extracted by skeletal muscle in subjects with type 2 diabetes and control subjects. Diabetes 51:784-789